Allstocks.com's Bulletin Board Post New Topic  New Poll  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Micro Penny Stocks, Penny Stocks $0.10 & Under » ONCO-.028 huge news yesterday!

 - UBBFriend: Email this page to someone!    
Author Topic: ONCO-.028 huge news yesterday!
matto
Member


Member Rated:
4
Icon 7 posted      Profile for matto         Edit/Delete Post   Reply With Quote 
[Big Grin] Watch this close

Higher highs!!!!!!


 -

--------------------
Trading is a blast!!

Posts: 4921 | From: Rhode Island | Registered: May 2005  |  IP: Logged | Report this post to a Moderator
matto
Member


Member Rated:
4
Icon 1 posted      Profile for matto         Edit/Delete Post   Reply With Quote 
Yesterdays news


Oncology Med's Three Year Contract to Treat Prostate Cancer for Affiliate of Largest Health Care System in Ohio on Track to Exceed Financial Goals
Wednesday January 23, 9:00 am ET


Oncology Med Projecting $400,000.00 of Increased Revenue From Contract and Has Treated 15 Patients During the First Two Months of the Contract


PITTSBURGH, PA--(MARKET WIRE)--Jan 23, 2008 -- Oncology Med, Inc. (Other OTC:ONCO.PK - News) a Pittsburgh based cancer treatment solutions group, announced today that it is on track to exceed its financial projection for its new multiple year exclusive contract with Humility of Mary Health Partners, a division of Catholic Healthcare Partners, the largest health system in Ohio and the seventh largest not-for-profit health system in the United States. During the first two months of this contract, Oncology Med has fifteen patients under treatment with four having completed the full course of treatments.
ADVERTISEMENT


This exclusive multi-year contract will have Oncology Med providing physics and full turnkey prostate cancer brachytherapy services, equipment, staff, and radionuclide seed management to the system's hospitals of St. Elizabeth Medical Center, St. Elizabeth Boardman Medical Center, and St. Joseph's Medical Center, all of which are located in the greater Youngstown, Ohio area.

According to William Walker, Ph.D., Oncology Med's CEO and founder, "The early financial success of our turnkey prostate treatment program has proven the viability of the Oncology Med model. At the current rate of new patient growth, we can anticipate gross revenues from this contract to exceed earlier projections and is expected to approach $400,000.00 this year. This is a 25% increase over the projected revenues expected at the time the contract was awarded to our company. We are committed to expand our client base by entering into similar contracts with a variety of healthcare organizations, resulting in additional revenue increases."

Jack Sloan, Vice President of Business Development, added, "While only in the early months of this program, the high number of patients being treated under our program is an early indication that many patients are indeed choosing radiation therapy as their treatment of choice for prostate cancer as has been indicated by several studies. Our turnkey brachytherapy program gave the hospital the ability to concentrate on the patients and physicians associated with the treatment of prostate cancer and kept it from having to worry and devote time to the many moving parts of implementing a new brachytherapy seed radiation program from beginning to end. Due to our expertise and clinical experience in this area, Oncology Med had the hospital's brachytherapy seed program in place inside of thirty (30) days, which allowed the physicians to immediately begin referring patients to the treatment at their local hospital," Sloan continued.

About Oncology Med, Inc.

Oncology Med is a public company engaged in the fulfillment of services related to the treatment of various cancers. It currently provides analysis and design of radiation treatment plans in order for radiation oncologists to administer radiation treatments to cancer patients. Current services facilitate radiation treatment programs ranging from external beam radiation to more advanced radiation treatment technologies.

More information about Oncology Med, Inc. can be found at http://www.oncologymed.com.

--------------------
Trading is a blast!!

Posts: 4921 | From: Rhode Island | Registered: May 2005  |  IP: Logged | Report this post to a Moderator
matto
Member


Member Rated:
4
Icon 1 posted      Profile for matto         Edit/Delete Post   Reply With Quote 
Number of Employees
8 as of Sep 1, 2007
SEC Reporting Status
non-SEC Reporting Company
Fiscal Year End
10/31
Estimated Market Cap
1,543,512.225 as of Jan 18, 2008
Outstanding Shares
61,740,489 as of Jul 31, 2007
Authorized Shares
200,000,000 as of Jan 8, 2008
Float
2,500,000 as of Sep 1, 2007

--------------------
Trading is a blast!!

Posts: 4921 | From: Rhode Island | Registered: May 2005  |  IP: Logged | Report this post to a Moderator
matto
Member


Member Rated:
4
Icon 1 posted      Profile for matto         Edit/Delete Post   Reply With Quote 
Rocking today!!!!!!!!!!!!!!!!!!!

--------------------
Trading is a blast!!

Posts: 4921 | From: Rhode Island | Registered: May 2005  |  IP: Logged | Report this post to a Moderator
matto
Member


Member Rated:
4
Icon 1 posted      Profile for matto         Edit/Delete Post   Reply With Quote 
anyone get some?

--------------------
Trading is a blast!!

Posts: 4921 | From: Rhode Island | Registered: May 2005  |  IP: Logged | Report this post to a Moderator
matto
Member


Member Rated:
4
Icon 1 posted      Profile for matto         Edit/Delete Post   Reply With Quote 
 -

--------------------
Trading is a blast!!

Posts: 4921 | From: Rhode Island | Registered: May 2005  |  IP: Logged | Report this post to a Moderator
classified
Member


Icon 1 posted      Profile for classified     Send New Private Message       Edit/Delete Post   Reply With Quote 
Hey Matto! I picked some up the other day at .031 and .032...Its gonna rock!!!

Do you know what the float is?

-$w

Posts: 1075 | From: weeeeeeee | Registered: Sep 2007  |  IP: Logged | Report this post to a Moderator
IMAKEMONEY
Member


Icon 1 posted      Profile for IMAKEMONEY     Send New Private Message       Edit/Delete Post   Reply With Quote 
Float
2,500,000 as of Sep 1, 2007

--------------------
LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!

Posts: 9276 | From: San Diego CA | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
classified
Member


Icon 1 posted      Profile for classified     Send New Private Message       Edit/Delete Post   Reply With Quote 
That weird IMAKE:

Detailed Quote for Oncology Med Inc. (ONCO)
$ 0.033 0.005 (+17.86%) Volume: 2.76 m 3:59 PM EST Jan 25, 2008

Volume was 2.76 million on friday!

Something is wrong.

-$w

Posts: 1075 | From: weeeeeeee | Registered: Sep 2007  |  IP: Logged | Report this post to a Moderator
IMAKEMONEY
Member


Icon 1 posted      Profile for IMAKEMONEY     Send New Private Message       Edit/Delete Post   Reply With Quote 
DILUTION LOOK AT THE DATE Sep 1, 2007 [Wink]

--------------------
LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!

Posts: 9276 | From: San Diego CA | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
classified
Member


Icon 1 posted      Profile for classified     Send New Private Message       Edit/Delete Post   Reply With Quote 
You may be right IMAKE...but up 15% today..weeeeeehhhhheeeeeeeehehe!
Posts: 1075 | From: weeeeeeee | Registered: Sep 2007  |  IP: Logged | Report this post to a Moderator
classified
Member


Icon 1 posted      Profile for classified     Send New Private Message       Edit/Delete Post   Reply With Quote 
Posted by: SelTzer
In reply to: redsoxnumba1 who wrote msg# 1008 Date:1/28/2008 9:21:26 PM
Post #of 1020

These guys are the hottest micro cap stock pickers on the internet. Looks like they see the same thing you see. Looks like double digits on the way. Check it out, good choice.


http://www.ericdavid.com/newsletter/mailer/onco012808.html
--------------------------------

February Company of the Month
EricDavid & Sons, Inc rates Oncology Med, Inc (PinkSheets: ONCO) "Aggressive out perform Strong Buy"


(PINKSHEETS: ONCO)
Shares Authorized 200Mil
Shares Outstanding 61Mil
Est Public Float 25Mil
52 week high $1.28
52 week low $0.009
January 28th closing price $0.034

Dear Readers,

I came across two very nice public companies which are both in the very same business of Radiation Therapy Services Centers. The only thing different is that one company is a giant in this field and the other is a start up. The amazing thing about these two companies is that they are the only public companies in this sector. Radiation Therapy Services (NASDAQ:RTSX) currently trading at $27.32 had been a monopoly the only public company in the industry. RTSX did $100million in revenue for their 2nd QT earning a net income of $10Million. Now get a load of this, on Oct 19, 2007 Vestor Capital Partners agreed to acquire RTSX for a whopping $32.50 a share a deal worth $1.1 Billion dollars.


Now comes along our little unknown gem in the exact same medical field doing the exact same thing as RTSX. Oncology Med, Inc (PINKSHEETS: ONCO) This beauty of a Company has already secured two million dollars in Contracts and is aggressively expanding their Radiation Therapy Services Centers in PA and OH. Could this little baby become the very next RTSX? Well that’s why EDS profiles, follows and brings you these unique Companies which in fact can become the next Wall Street darlings. When you read this Company Profile, I am sure that you will see what we’ve discovered for you in an undervalued situation.


Oncology Med, Inc. is a public company engaged in the fulfillment of a variety of services related to the treatment of various cancers. We currently provide analysis and design of radiation treatment plans in order for radiation oncologists to administer various radiation treatment plans to cancer patients. Our services facilitate radiation treatment programs ranging from external beam radiation to more advanced radiation treatment technologies.

Our mission is to be a pioneer in the advancement of the treatment of cancers. We plan on growing our business through acquisitions in addition to the organic growth of our subsidiary, Comprehensive Physics and Regulatory Services (“CPRS”).

CPRS has pioneered the use of the internet for clinical radiation oncology treatment planning. The service was commenced over ten years ago in an effort to provide cost effective treatment planning by smaller radiation/cancer centers through the sharing of expertise and resources. Medical records including MRI and X-Rays are sent over the internet which allow our staff of physicists and dosemitrists to turn around a fully developed treatment plan in less that 24 hours.

Today our clients range from world class cancer treatment centers to local and regional cancer treatment centers. We have continued to grow in the scope of our services offered and in the geographical areas served, supporting over 25 radiation oncology centers from Florida to New England. Expansion opportunities exist both domestically and internationally.

Our team consists of industry professionals from many countries around the world. We leverage our experience through collaboration, professional development, training and technology. Our organizational structure is comprised of Physicists, Dosimetrists, Radiation Oncologists, Medical Technologists and Medical Business Consultants.

William J. Walker, Ph.D., CHP , PE
Chairman of the Board

Dr. Walker is Chairman of the Board of Oncology Med. Inc., and is President and Chief Executive Officer of Comprehensive Physics & Regulatory Services, Ltd. (“CPRS”). Dr. Walker is a medical physicist with over 40 years of clinical practice, research and program management. He holds a B.S. in Civil Engineering from the Virginia Military Institute, an M.S. in Radiation Biophysics from the University of Kansas, and a Ph. D. from the University of Florida in Environmental Engineering (Medical Physics). He is certified by the American Board of Health Physics, licensed by the State of Florida as a Therapeutic Radiological Physicist and is a registered professional engineer. Dr. Walker retired from the U.S. Air Force in 1978 as a Lt. Col. And was the Chief of Medical Physics for a major USAF Medical Center. Following his retirement from the Air Force, he headed the US Nuclear Regulatory Commission’s medical and academic licensing program and later was the Radiation Safety Officer and Program Director for the National Institute of Health, the largest such program of its kind in the world. He is the author of numerous papers on medical and health physics and a corporate officer and member of the Board of Directors of Advanced Oncology Network, Inc. Dr. Walker is additionally a member of the Boards of Directors of Eureka Cancer Treatment Center, Ltd. and Universal Healthcare Management Systems, Inc.


G. Stephen Brown, M.D., FACR

Dr. Brown is a Professor of Radiation Oncology at the University of Texas M.D. Anderson Cancer Center in Houston. His professional activities are dedicated entirely to peer review and standard applications in Cancer treatments. He received his B.A. in zoology from U.C.L.A. and his M.D. from the University of Ottowa Faculty of Medicine in 1963. After serving a general rotating internship at Cedars-Sinai Medical Center in Los Angeles, he began a 4 year residency in radiation oncology. The first year was at the Cedars – Sinai Medical Center, Los Angeles, CA. The remaining three years were at the Penrose Cancer Hospital in Colorado Springs, CO. The final five months were at the Puerto Rico Nuclear Center in San Juan, Puerto Rico.

After achieving board certification in Therapeutic Radiology from the American Board of Radiology in 1968, he entered practice at the University of Vermont. He served in the U.S. Army Medical Corps at the rank of Major from 1969 to 1972 where he served as Chief of Radiation Therapy and Chief of Nuclear Medicine, Honolulu, Hawaii. He returned to the University of Vermont as Director of Radiation Oncology through 1977. He wss in private practice of radiation oncology from 1977-1990. He was a consultant to the Cancer Department of the World Health Organization from 1990 – 1991. From 1992-1993 he was Associate Director, Division of Cancer Treatment, Radiation Research Branch at the National Cancer Institute. From 1993-1995 he served as Medical Director of Oncology Services Corporation. Since 1995, he has been the Associate Director for Radiation Oncology at the UT M.D..

Mitchell Jarosz, M.S., DABR

Mr. Jarosz received his BS in physics from Duquesne University and attended the Carnegie Mellon Institute for his MS in Radiological Physics. He worked as a staff physicist at St. Francis Medical Center, Pittsburgh, PA for 16 years where he gained experience in commissioning and maintaining various types of radiation therapy equipment,. His experience includes beam data collection, entry and commissioning of treatment planning computers including: ADAC, Multimedia, CMS and Medicalibration PC#D. He is experienced in performing diagnostic calibrations on various x-ray systems including R/F, CT (GE, Elscint, Siemens and Picker), dental ultrasound and mammography units. He has established quality assurance programs and physics protocols for a number of centers for a variety of treatment modalities. He has held course of instruction in diagnostic radiology and nuclear medicine for residents and technologists.


I’m sure you enjoyed this read and that you agree we are on to something great. Keep a look out for our text interview with the CEO next week.


Regards,
Steve Weiss
Publisher


Posts: 1075 | From: weeeeeeee | Registered: Sep 2007  |  IP: Logged | Report this post to a Moderator
classified
Member


Icon 1 posted      Profile for classified     Send New Private Message       Edit/Delete Post   Reply With Quote 
WEEEEHAWWWWWWW!!!!!


Oncology Med Enters Into Letter of Intent to Acquire Medical/Radiation Company Which Has Gross Revenues of $2,800,000.00
Upon the Closing, Oncology Med Will Have an Annual Revenue Run Rate of $5,000,000.00
Oncology Med, Inc. (PINKSHEETS: ONCO) a Pittsburgh based cancer treatment solutions group, announced today that it has entered into a letter of intent to acquire a synergistic company in the field of physics and radiation that has annual revenues of $2,800,000.00, operates on a national scale, and is profitable. Upon the closing of this acquisition, which is subject to due diligence review by both parties and the execution of definitive agreements of purchase, the combined entity will have an annual revenue run rate of $5,000,000.00. The Company is prevented from announcing the name of the acquisition candidate until the completion of the due diligence period and execution of a definitive agreement of purchase.

According to William Walker, Ph.D., Oncology Med's CEO and founder, "We are extremely excited about the agreement we have entered into to acquire this company and intend to move diligently and expediently toward a closing which we expect to occur on or about May 2008. The company is a leader in their field and presents many cross marketing opportunities for us. The management has a pristine reputation and credentials and will be a great addition to the Oncology Med team. I believe this will be one of many acquisitions that we will pursue. As always our plan is to take advantage of our organic growth in addition to exciting and accretive acquisitions."

About Oncology Med, Inc.

Oncology Med is a public company engaged in the fulfillment of services related to the treatment of various cancers. It currently provides analysis and design of radiation treatment plans in order for radiation oncologists to administer radiation treatments to cancer patients. Current services facilitate radiation treatment programs ranging from external beam radiation to more advanced radiation treatment technologies.

Posts: 1075 | From: weeeeeeee | Registered: Sep 2007  |  IP: Logged | Report this post to a Moderator
lukin4winners
Member


Rate Member
Icon 1 posted      Profile for lukin4winners     Send New Private Message       Edit/Delete Post   Reply With Quote 
Great news this morning...the is a real gem:

Expected to Reach $300,000.00
Feb 5, 2008 7:00:00 AM
View Additional ProfilesPITTSBURGH, PA -- (MARKET WIRE) -- 02/05/08 -- Oncology Med, Inc. (PINKSHEETS: ONCO), a Pittsburgh-based cancer treatment solutions group, announced today that it has begun the acceptance testing on the linear accelerator for its new multi-year exclusive contract with the Meadville Medical Center in Meadville, Pennsylvania. Oncology Med is providing Meadville's state of the art full service cancer treatment center with a complete range of medical physics support to include radiation shielding design and analysis, equipment acceptance and commissioning and on-going medical physics consulting services. Oncology Med was selected by Meadville over several competitors.

"Once completed, our Company will be able to provide a variety of additional medical physics services which will result in increased revenue results beginning in April 2008 and continuing throughout the term of our multi-year contract with Meadville Medical Center. Our continued on time achievements of goals and initiatives which were laid out at the end of 2007 will only result in increased revenues and new client opportunities as we go forward in our fiscal year 2008," stated William Walker, Ph.D., Oncology Med's CEO and founder.

"We are excited to have been made a part of this innovative project and are anticipating completion of the acceptance and commissioning phase on time and within budget. The multi-million dollar linear accelerator treatment unit is the heart of the facility and its reliability and accuracy are paramount concerns to the cancer center. Oncology Meds professional medical physics team's goal is to have the accelerator ready for clinical tests by early April 2008

Posts: 660 | From: california | Registered: Nov 2005  |  IP: Logged | Report this post to a Moderator
lukin4winners
Member


Rate Member
Icon 1 posted      Profile for lukin4winners     Send New Private Message       Edit/Delete Post   Reply With Quote 
ONCO on a very impressive reversal from .015 to .026 moving on air worth taking a look. Possibly news coming.
Posts: 660 | From: california | Registered: Nov 2005  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share